Monopar Therapeutics Inc. ( MNPR) - Key Metrics
MNPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.62 | -$380.15 | -$380.15 |
| 2026Q1 | $0 | -$0.46 | -$0.41 | -$0.41 |
| 2025Q4 | $0 | -$0.78 | -$0.50 | -$0.50 |
| 2025Q3 | $0 | -$0.48 | -$0.29 | -$0.29 |
| 2025Q2 | $0 | -$0.35 | -$0.15 | -$0.15 |
MNPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -37.33 |
| 2026Q1 | 0% | -29.78 |
| 2025Q4 | 0% | -20.93 |
| 2025Q3 | 0% | -42.54 |
| 2025Q2 | 0% | -25.56 |
MNPR
Price: $69.27
52 week price:
Earnings Per Share: -2.26 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123422
Market Capitalization: 522.3 million